This study investigates the relationship between tweet sentiment across diverse categories: news, company opinions, CEO opinions, competitor opinions, and stock market behavior in the biotechnology sector, with a focus on understanding the impact of social media discourse on investor sentiment and decision-making processes. We analyzed historical stock market data for ten of the largest and most influential pharmaceutical companies alongside Twitter data related to COVID-19, vaccines, the companies, and their respective CEOs. Using VADER sentiment analysis, we examined the sentiment scores of tweets and assessed their relationships with stock market performance. We employed ARIMA (AutoRegressive Integrated Moving Average) and VAR (Vector AutoRegression) models to forecast stock market performance, incorporating sentiment covariates to improve predictions. Our findings revealed a complex interplay between tweet sentiment, news, biotech companies, their CEOs, and stock market performance, emphasizing the importance of considering diverse factors when modeling and predicting stock prices. This study provides valuable insights into the influence of social media on the financial sector and lays a foundation for future research aimed at refining stock price prediction models.

As we saw in our first blog post on AI Everywhere and Nowhere, defining'Artificial Intelligence' is like trying to hit a disappearing target. As soon as any aspect of AI gains widespread adoption, people fail to distinguish it as an AI technology, and it dissolves into the sea of general technology. As a result, most detractors of AI, at least until recently, have questioned the real-world applications of AI. In turn, AI never gains the respect and recognition it needs to evolve and reach its full potential. The beauty (and bane) of AI is that it is everywhere and yet nowhere – it is becoming ubiquitous in all of our interactions (at least all of our'virtual interactions'), yet most people fail to recognize and respect it.